Learn More
Medchemexpress LLC NUCC-390 | 1060524-97-1 | 98.40% | 395.54 | 10 MG

Supplier: Medchemexpress LLC HY11179310MG
NUCC-390 is a novel and selective small-molecule CXCR4 receptor agonist. It induces internalization of CXCR4 receptors and promotes nerve recovery of function after neurodegeneration in vivo.
- Novel and selective small-molecule CXCR4 receptor agonist.
- Induces internalization of CXCR4 receptors.
- Acts in an opposite way of AMD3100.
- Promotes nerve recovery of function after neurodegeneration in vivo.
- Produces strong (Ca)i response, which can be blocked by AMD3100.
- Increases levels of pERK, stimulating signaling activity downstream of CXCR4 receptors.
- Induces CXCR4 receptor internalization in HEK cells.
- Boosts axonal growth in cultured cerebellar granule neurons (CGNs) via CXCR4.
- Contributes to the functional and anatomical recovery of the neuromuscular junction (NMJ) following acute nerve terminal damage in CD-1 mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.